Novel p38 inhibitors with potent oral efficacy in several models of rheumatoid arthritis
Authors:
- 30 April 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (13) , 3595-3599
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- SAR of 2,6-diamino-3,5-difluoropyridinyl substituted heterocycles as novel p38MAP kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2002
- Chapter 18. Inhibitors of p38α MAP kinase2002
- SAR of 4-hydroxypiperidine and hydroxyalkyl substituted heterocycles as novel p38 map kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2000
- Structural basis of inhibitor selectivity in MAP kinasesStructure, 1998
- Stannylation reaction and cross-couplings in pyrimidinesTetrahedron, 1989